HT
MYGN icon

Headlands Technologies’s Myriad Genetics MYGN Stock Holding History

Headlands Technologies’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.5K Sell
10,062
-95,352
-90% -$433K 0.01% 677
2026
Q1 		$474K Buy
105,414
+18,622
+21% +$97K 0.05% 371
2025
Q4 		$534K Buy
86,792
+10,402
+14% +$75.4K 0.04% 386
2025
Q3 		$552K Sell
76,390
-7,529
-9% -$44.7K 0.04% 343
2025
Q2 		$446K Buy
83,919
+37,192
+80% +$220K 0.05% 326
2025
Q1 		$414K Buy
46,727
+24,958
+115% +$300K 0.05% 321
2024
Q4 		$298K Buy
21,769
+15,731
+261% +$290K 0.03% 442
2024
Q3 		$165K Sell
6,038
-586
-9% -$15.9K 0.02% 563
2024
Q2 		$162K Buy
+6,624
New +$145K 0.02% 517

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Headlands Technologies's MYGN Position: Q2 2026 in Review

Headlands Technologies reduced its Myriad Genetics (MYGN) stake by 90% in Q2 2026, selling an estimated $433K and leaving 10,062 shares worth $57.5K. The position accounts for 0.01% of the portfolio, ranked #677.

Headlands Technologies first reported a position in MYGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $552K in Q3 2025. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Headlands Technologies held 10,062 shares of Myriad Genetics worth $57.5K as of Q2 2026.
  • Headlands Technologies sold 95,352 Myriad Genetics shares in Q2 2026, an estimated $433K.
  • Myriad Genetics made up 0.01% of Headlands Technologies's portfolio in Q2 2026, its #677 holding.
  • Headlands Technologies first reported a position in Myriad Genetics in Q2 2024 and has held it in 9 quarters since.
  • Headlands Technologies's Myriad Genetics position peaked at $552K in Q3 2025.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.